PROPHYLAXIS AND THERAPY OF FUNGAL-INFECTIONS IN ONCOLOGY

被引：3

作者：

SCHULER, U ^{[1
]}

MOLLE, M ^{[1
]}

EHNINGER, G ^{[1
]}

机构：

[1] TECH UNIV DRESDEN,KLINIKUM CARL GUSTAV CARUS,MED KLIN 1,DRESDEN,GERMANY

来源：

MYCOSES | 1995年 / 38卷

关键词：

OPPORTUNISTIC MYCOSES; NEUTROPENIA; ONCOLOGY; ANTIMYCOTIC PROPHYLAXIS; ANTIMYCOTIC CHEMOTHERAPY;

D O I：

10.1111/j.1439-0507.1995.tb00484.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

The observation of a considerable incidence of fungal infections in oncology patients has promoted a large number of studies both on prophylaxis and treatment in this patient group. Trials using triazoles, especially fluconazole, have shown effect in preventing fungal infections. In neutropenic patients, their role in therapy still remains less clear. Amphotericin B is the drug of choice for most life-threatening infections. With this drug, efforts concentrate upon the amelioration of side effects by sodium loading, administration in lipid emulsions or liposomes. The use of AMB as low-dose systemic prophylaxis or by inhalation needs further study.

引用

页码：45 / 50

页数：6

共 51 条

[21] A CONTROLLED TRIAL OF FLUCONAZOLE TO PREVENT FUNGAL-INFECTIONS IN PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION [J].

GOODMAN, JL ;

WINSTON, DJ ;

GREENFIELD, RA ;

CHANDRASEKAR, PH ;

FOX, B ;

KAIZER, H ;

SHADDUCK, RK ;

SHEA, TC ;

STIFF, P ;

FRIEDMAN, DJ ;

POWDERLY, WG ;

SILBER, JL ;

HOROWITZ, H ;

LICHTIN, A ;

WOLFF, SN ;

MANGAN, KF ;

SILVER, SM ;

WEISDORF, D ;

HO, WG ;

GILBERT, G ;

BUELL, D .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (13) :845-851

[22]

GOODMAN JL, 1994, NEW ENGL J MED, V40, P136

[23] TREATMENT OF CANDIDA-ALBICANS FUNGEMIA WITH FLUCONAZOLE [J].

GRANINGER, W ;

PRESTERIL, E ;

SCHNEEWEISS, B ;

TELEKY, B ;

GEORGOPOULOS, A .

JOURNAL OF INFECTION, 1993, 26 (02) :133-146

[24] RISK-FACTORS FOR FUNGAL INFECTION IN PATIENTS WITH MALIGNANT HEMATOLOGIC DISORDERS - IMPLICATIONS FOR EMPIRICAL THERAPY AND PROPHYLAXIS [J].

GUIOT, HFL ;

FIBBE, WE ;

VANTWOUT, JW .

CLINICAL INFECTIOUS DISEASES, 1994, 18 (04) :525-532

[25] EFFECT OF IMMUNOSUPPRESSION ON THE DEVELOPMENT OF EXPERIMENTAL HEMATOGENOUS CANDIDA ENDOPHTHALMITIS [J].

HENDERSON, DK ;

HOCKEY, LJ ;

VUKALCIC, LJ ;

EDWARDS, JE .

INFECTION AND IMMUNITY, 1980, 27 (02) :628-631

[26] LOW INCIDENCE OF INVASIVE FUNGAL-INFECTIONS AFTER BONE-MARROW TRANSPLANTATION IN PATIENTS RECEIVING AMPHOTERICIN-B INHALATIONS DURING NEUTROPENIA [J].

HERTENSTEIN, B ;

STEFANIC, M ;

NOVOTNY, J ;

KERN, WV ;

BUNJES, D ;

HEIMPEL, H ;

SCHMEISER, T ;

WIESNETH, M ;

ARNOLD, R .

ANNALS OF HEMATOLOGY, 1994, 68 (01) :21-26

[27] TREATMENT OF ASPERGILLOSIS WITH ITRACONAZOLE [J].

JENNINGS, TS ;

HARDIN, TC .

ANNALS OF PHARMACOTHERAPY, 1993, 27 (10) :1206-1211

[28] IN-VITRO RENAL TOXICITY AND IN-VIVO THERAPEUTIC EFFICACY IN EXPERIMENTAL MURINE CRYPTOCOCCOSIS OF AMPHOTERICIN-B (FUNGIZONE) ASSOCIATED WITH INTRALIPID [J].

JOLY, V ;

FARINOTTI, R ;

SAINTJULIEN, L ;

CHERON, M ;

CARBON, C ;

YENI, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (02) :177-183

[29] POLYMERASE CHAIN-REACTION FOR THE DIAGNOSIS OF CANDIDEMIA [J].

KAN, VL .

JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (03) :779-783

[30]

KARP JE, 1991, REV INFECT DIS, V13, P592

← 1 2 3 4 5 6 →